The documents below are related to the City of Philadelphia’s academic detailing campaign promoting naloxone co-prescribing by healthcare providers in Philadelphia.
Evaluation of public health detailing visit: If you have participated in a public health detailing visit, please complete this brief evaluation, led by the University of Pittsburgh. It will take less than 5 minutes and all responses are anonymous. Thank you for your time.
|Introductory Cover Letter PDF||March 29, 2022|
|Prescription Opioid and Benzodiazepine Use in Philadelphia, 2017 PDF||March 11, 2022|
|Unintentional Overdose Fatalities in Philadelphia, 2020 PDF||March 11, 2022|
|Health Alert – Counterfeit Pills, 2020 PDF||March 11, 2022|
|Prescribing Guidance for Clinical Settings PDF||March 11, 2022|
|Talking to Patients About Naloxone PDF||March 16, 2022|
|Prescribing Naloxone to Patients PDF||March 16, 2022|
|For Patients – Getting Naloxone in Pharmacies FAQ PDF||March 11, 2022|
|For Patients – Pennsylvania Naloxone Copay Assistance Program PDF||March 11, 2022|
|Study of Naloxone Coprescription for Patients Receiving Long-Term Opioid Therapy for Pain (Annals of Internal Medicine) PDF||March 11, 2022|